Table: Noile-Immune Biotech - 9-MTH parent results

Noile-Immune Biotech

13/11/2023 07:00

Nov 13 (Reuters)- 
             Noile-Immune Biotech Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Sep 30, 2023        Sep 30, 2022      Dec 31, 2023  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            314 mln                               319 mln    
                                                       (-49.0 pct)  
  Operating     loss 495 mln                            loss 1.54   
  Recurring     loss 848 mln                            loss 1.83   
  Net           loss 850 mln                            loss 1.83   
  EPS          loss 20.81 yen                        loss 44.27 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Noile-Immune Biotech Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4893.T